A

California bill aimed at providing transparency into prescription drug pricing moved a step closer to reality on Wednesday when a Senate committee approved the legislation.

In a 7 to 2 vote, the state’s Senate Health Committee supported the idea that drug makers should notify state officials about planned price hikes and also justify those increases. The legislation would also require health plans to provide detailed information about drug costs and the portion of premiums attributed to this expense.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy